In a landmark announcement that sent shockwaves through the biotech sector, Nurix Therapeutics, Inc. shares climbed an impressive 14.2% in the last trading session, closing at a robust $12.14. This surge in stock value was backed by a significant increase in trading volume, with a far higher number of shares changing hands than typically observed […]